Moderate Evidenz
Safety: Likely safe
Study dose: 30 mg/day
Saffron (Crocus sativus)
Also known as: Crocus sativus, Saffron extract, Saffron supplement
Summary Moderate Evidenz
Saffron is mainly studied for mood, stress, and PMS. Human trials are interesting, but still too small and narrow to justify broad health claims or premium pricing narratives.
EU Health Claims: No approved claims
There are no approved EU health claims for saffron. Positive trials on mood or stress do not allow free marketing claims about antidepressant, calming, or broader health effects.
🤖AI Summary
Quick verdict
Saffron is mainly studied for mood, stress, and PMS. Human trials are interesting, but still too small and narrow to justify broad health claims or premium pricing narratives.
What the evidence supports
There are multiple small randomized human trials and meta-analyses on saffron, especially for depressive symptoms and in some cases anxiety, PMS, or sleep. Results are often positive, but the evidence base remains limited: small samples, short durations, and heavy dependence on a few research groups.
What is NOT supported
Long-term safety and rare adverse effects in humans remain insufficiently studied.
EU/EFSA status
Not approved. There are no approved EU health claims for saffron. Positive trials on mood or stress do not allo…
Safety
Likely safe
This AI summary is generated from the structured data on this page.
What is saffron?
Saffron is the dried stigma of Crocus sativus. As a culinary spice it is famously expensive; as a supplement it is usually sold as a standardised extract. In research, saffron is less about broad longevity promises and more about mood, stress, PMS, and in some cases sleep.
What does the evidence show?
Mood and depressive symptoms
This is where most of the human evidence sits. Several small randomized trials and meta-analyses suggest that saffron can perform better than placebo in mild to moderate depressive symptoms, and in some studies it appeared similar to standard antidepressants.
That sounds impressive, but the limitations matter:
many studies are small
follow-up is usually short
a large share of the literature comes from a limited number of research groups
results do not automatically translate into routine clinical practice
Stress, anxiety, sleep, PMS
There are also positive signals here, but the evidence base is thinner than for depressive symptoms. That makes saffron more of an interesting candidate than a clearly established multi-purpose supplement.
Is saffron worth it as a supplement?
That is the right question, because saffron is almost always more expensive than simpler alternatives. The current evidence is good enough to call it scientifically interesting — not good enough to claim that the high price is clearly justified on health grounds alone.
At typical study doses of around 15–30 mg/day, saffron is generally well tolerated. Reported adverse effects are usually mild: gastrointestinal upset, headache, or dry mouth. Extra caution makes sense in:
pregnancy (avoid higher doses)
bipolar disorder
very high-dose products without clear standardisation
Verdict
Saffron is more than expensive-spice marketing — but it is not a clearly proven premium health supplement either. Mood-related outcomes show the most interesting human data. That is still not enough to justify broad health promises or to claim that the price is obviously worth it.
Key Studies
Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials
Hausenblas HA et al. (2013)
Early meta-analysis: saffron outperformed placebo and in small studies appeared comparable to antidepressants in mild to moderate depression.
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.